Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.4350 (4.35%) ($10.4350 - $10.4750) on Fri. Jan. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.74% (three month average) | RSI | 41 | Latest Price | $10.4350(4.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.4% a day on average for past five trading days. | Weekly Trend | BCRX declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(35%) XBI(32%) IBB(28%) SDY(26%) IFRA(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.87% in a week (0% probabilities). VIXM(-17%) UUP(-10%) VXX(-7%) USO(-1%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.87% (StdDev 3.74%) | Hourly BBV | 2.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.6(-105.75%) | Resistance Level | $10.82 | 5 Day Moving Average | $10.14(2.91%) | 10 Day Moving Average | $10.39(0.43%) | 20 Day Moving Average | $10.82(-3.56%) | To recent high | -26% | To recent low | 4.4% | Market Cap | $1.841b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |